Charlotte Robinson

DocwireNews

The impact of antenatal glucocorticoid exposure on children&rsquo;s health is unclear. Researchers led by You-Lin Tain, MD, PhD, examined the association between gestational exposure to maternal systemic glucocorticoids (SG) and risk of developing CKD in childhood. Their retrospective cohort study focused on newborns receiving care at Taiwan&rsquo;s largest health care system between 2004 and 2018. Maternal prescriptions for SG between the last menstrual period and childbirth served as a proxy for gestational exposure.&nbsp;The primary study outcome was incidence of childhood CKD, including congenital anomalies of the kidney and urinary tract (CAKUT) and other kidney diseases (non-CAKUT) over 10 years. The researchers used Cox proportional hazards models with stabilized inverse probability of treatment weighting and a robust sandwich estimator to measure the average association between SG and incident CKD after adjusting for offspring characteristics (aHR).&nbsp;A total of 23,363 singleton children were included in the study. Their gestational SG exposure was significantly associated with a higher risk of childhood CKD (aHR, 1.69 [95% CI, 1.01-2.84]). Stratified analyses found stronger associations between SG and childhood CKD within the strata of total dose of hydrocortisone equivalent &gt;24 mg (aHR, 1.91 [95% CI, 1.05-3.47), birth &lt;37 weeks gestational age (aHR, 2.38 [95% CI, 1.19-4.78]), male sex (aHR, 1.89 [95% CI, 1.00-3.55]), and gestational exposure in the second trimester (aHR, 6.70 [95% CI, 2.17-20.64]).&nbsp;&nbsp;These findings suggest that gestational exposure to SG is associated with CKD in childhood. If further studies confirm these results, they may help enlighten clinicians who are considering prescribing SG during pregnancy.&nbsp;Source: <a href="https://doi.org/10.1053/j.ajkd.2024.01.523" target="_blank" rel="noopener">American Journal of Kidney Diseases</a>&nbsp;

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Gestational Exposure to Glucocorticoids, CKD Risk

Chronic Kidney Disease

A study examined gestational exposure to maternal systemic glucocorticoids and risk of developing CKD in childhood.

Gestational Exposure to Glucocorticoids, CKD Risk  

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe